BioSpace News Archive

Samsung Biologics (207940.KS) announced the appointment and expansion of its board of directors at its 9 th annual general meeting of shareholders that took place on March 20 th . In the course of expanding its business model from a contract manufacturing (CMO) company to development (CDO) and research (CRO) services, Samsung

Arcadia Consumer Healthcare, Inc., a recognized leader in the consumer healthcare industry, announced that is has completed the acquisition of the U.S. rights to the Kaopectate® brand from Sanofi.

Innovator in metagenomic testing partners with leading biotech companies to increase critical COVID-19 testing capacity immediately

On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019 , the completion of which is still subject

March 20, 2020 12:30 UTC Series A Financing Funds Novel Pipeline for Patients with Nucleotide Repeat Disorders Company Advancing Lead Program for Friedreich’s Ataxia toward Clinical Development SAN DIEGO--( BUSINESS WIRE )-- Design Therapeutics announced today that it is launching to create and develop a new class of therapies for patients with serious degenerative disorders caused by nucleotide repeat expansions. The company has closed a $45 million Series A fina

Simultaneous approval of VOCABRIA (cabotegravir oral tablets), for short-term treatment in conjunction with CABENUVA (cabotegravir and rilpivirine extended-release injectable suspensions), also granted by Health Canada CABENUVA reduces treatment dosing days from 365 to 12 per year

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will be payable on April 17, 2020, to shareholders of record as of the close of business on April 3, 2020. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to approval by its Bo

Coherus BioSciences, Inc., announced that effective March 19, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 57,500 shares of the common stock of the Company to three newly hired non-officer employees, with a per share exercise price of $12.86, the closing trading price on the grant date.

CareDx, Inc. announces that the American Journal of Transplantation published a case report from Johns Hopkins on a successful kidney retransplantation in a patient who experienced rejection of a first kidney transplant after undergoing immune-stimulating therapy for the treatment of metastatic cutaneous squamous cell carcinoma.

Firetinas, invented by a group of scholars from Cambridge University and Manchester University, had successfully helped China to control corona virus.